With the finding that mismatch repair proteins such as MSH2 and MSH6 were identified as more common in subtype II tumors, it may be hypothesized that the Lynch syndrome-related endometrial cancer may be mainly subtype II EAC. Here, MSH6 is linked to Lynch syndrome.